Search research articles
Contact Us
Filters
Showing results (61-70 of 114) with videos related to
Page
of 12
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity
M A Alaoui-Jamali, L Panasci, G M Centurioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione
X Chen, R L Schecter, O W Griffith, et al.
Toxicologic Pathology
|
July 1, 1996
Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis
G M Kirby, G Batist, L Alpert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1996
Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response
T Wang, X Chen, R L Schecter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
G Batist, F Patenaude, P Champagne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group
K Swenerton, P Hoskins, G Stuart, et al.
Mutation Research
|
May 1, 1995
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
J Bramson, A McQuillan, R Aubin, et al.
Molecular Pharmacology
|
August 1, 1989
Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line
G Batist, S Torres-Garcia, J M Demuys, et al.
Molecular Pharmacology
|
September 1, 1990
Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells
V Skalski, D B Yarosh, G Batist, et al.
The Journal of Biological Chemistry
|
November 25, 1986
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
G Batist, A Tulpule, B K Sinha, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 114) with videos related to
Sort By:
Page
of 12
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity
M A Alaoui-Jamali, L Panasci, G M Centurioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione
X Chen, R L Schecter, O W Griffith, et al.
Toxicologic Pathology
|
July 1, 1996
Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis
G M Kirby, G Batist, L Alpert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1996
Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response
T Wang, X Chen, R L Schecter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
G Batist, F Patenaude, P Champagne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group
K Swenerton, P Hoskins, G Stuart, et al.
Mutation Research
|
May 1, 1995
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
J Bramson, A McQuillan, R Aubin, et al.
Molecular Pharmacology
|
August 1, 1989
Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line
G Batist, S Torres-Garcia, J M Demuys, et al.
Molecular Pharmacology
|
September 1, 1990
Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells
V Skalski, D B Yarosh, G Batist, et al.
The Journal of Biological Chemistry
|
November 25, 1986
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
G Batist, A Tulpule, B K Sinha, et al.
Page
of 12